PEITEL 2.5 mg/g OINTMENT

Introduction

Package Leaflet: Information for the User

Peitel 2.5 mg/g Ointment

prednicarbate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

1. What Peitel is and what it is used for
2. What you need to know before you use Peitel
3. How to use Peitel
4. Possible side effects
5. Storage of Peitel
6. Contents of the pack and other information

1. What Peitel is and what it is used for

Peitel contains the active substance prednicarbate, and belongs to a group of medicines called topical corticosteroids. This medicine is used on the skin to reduce inflammation, allergic reactions, redness, and oozing in inflamed skin.

Peitel is indicated for the treatment of symptoms (redness and itching) caused by certain inflammatory skin disorders that respond to topical treatment with corticosteroids, such as atopic dermatitis and psoriasis (excluding extensive plaque psoriasis).

2.

Do not use Peitel:

• If you are allergic to prednicarbate or any of the other ingredients of this medicine (listed in section 6)
• In the eyes, or on open wounds
• In areas of the skin that show a vaccination reaction, i.e. redness or inflammation after vaccination
• If you have tuberculosis, syphilis, or viral infections (e.g. chickenpox or herpes)
• In rosacea, acne, or skin thinning (atrophy)
• In inflammation around the mouth (perioral dermatitis).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Peitel.

• It should not be applied to large areas of the body or for a long period, as this significantly increases the risk of side effects. This medicine should be used at the lowest possible dose and only for the shortest time necessary to treat the skin condition.
• Avoid getting Peitel in your eyes, open wounds, or mucous membranes.
• If skin infections caused by bacteria or fungi develop, consult your doctor, who will establish additional specific treatment.
• If you use the medicine on skin folds (e.g. armpits or groin), you should be very careful because it can increase the absorption of the active ingredient.
• This medicine should not be used under airtight and waterproof dressings, such as bandages, dressings, or diapers, which are not very breathable.
• The use of topical corticosteroids in large areas or at high doses for a prolonged period increases the risk of side effects significantly.
• If you are being treated for psoriasis, strict medical supervision is recommended.
• Sudden discontinuation of treatment should be avoided. When long-term treatment with a potent corticosteroid is discontinued, a rebound effect may occur, characterized by intense redness, itching, and burning.
• Non-professional use of topical corticosteroids can mask symptoms and make diagnosis and correct treatment more difficult.
• Contact between Peitel and latex condoms should be avoided, as it may cause leaks or breaks in them.
• Consult your doctor if you experience blurred vision or other visual disturbances.

Children

This medicine is not recommended for use in children under 2 years of age due to the lack of clinical data in this population.

In children, the use of topical corticosteroids should be done with caution, limiting the dose to the lowest effective dose.

Using Peitel with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

No interactions with Peitel are known; however, other preparations should not be applied to the area being treated.

Pregnancy, breastfeeding, and fertility

Pregnancy

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

There are no sufficient data on the use of Peitel in pregnant women.

In general, during the first trimester of pregnancy, medicines containing corticosteroids should not be applied to the skin.

Breastfeeding

The safety of Peitel during breastfeeding has not been established, so its use is not recommended. Breastfeeding women should not apply the medicine to their breasts.

Driving and using machines

Peitel has no or negligible influence on the ability to drive and use machines.

Peitel contains benzyl alcohol

This medicine contains 10 mg of benzyl alcohol in each gram of ointment. Benzyl alcohol may cause allergic reactions and moderate local irritation.

3. How to use Peitel

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

This medicine is for external use only (to be applied to the skin).

The recommended dose is:

Adults and children over 2 years

Apply a thin layer of ointment to the affected area once or twice a day, rubbing gently.

Treatment may be reduced to once-daily application when significant improvement is observed.

The duration of treatment should not, as a general rule, exceed 4 weeks.

If you use the medicine for a condition on the face, the duration of treatment should be as short as possible and no more than one week.

After each application, wash your hands unless they are the treatment area.

Use in children

Peitel is not recommended for use in children under 2 years of age due to the lack of safety data.

In children, the use of topical corticosteroids should be done with caution, limiting the dose to the lowest effective dose.

If you use more Peitel than you should

If you significantly exceed the recommended doses, systemic corticosteroid effects cannot be ruled out.

In case of overdose or accidental ingestion, consult your doctor or pharmacist or go to a medical center, or call the Toxicology Information Service. Phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use Peitel

Do not apply a double dose to make up for forgotten doses.

Apply the corresponding dose when you remember, or wait until the next application if it is soon.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects of prednicarbate are generally local, mild, and transient. As with other topical corticosteroids, prolonged use of large quantities or treatment of extensive areas may lead to systemic corticosteroid effects due to absorption. If this occurs, topical treatment should be discontinued.

The possible side effects that may occur with this medicine are listed below by frequency:

Common side effects (may affect up to 1 in 10 people)

Skin and subcutaneous tissue disorders:

• mild to moderate burning sensation at the application site
• tingling sensation (paresthesia)
• itching (pruritus)
• bacterial infections
• furunculosis
• local skin thinning (atrophy)

Uncommon side effects (may affect up to 1 in 100 people)

Skin disorders:

• striae
• irritation
• hair growth on the skin (hypertrichosis)
• skin discoloration (hypopigmentation)
• perioral dermatitis
• skin maceration
• allergic contact dermatitis
• rosacea-like dermatitis (facial skin)
• acne-like reactions
• capillary fragility (ecchymosis)
• red or white bumps on various parts of the body (miliaria)
• dry skin
• folliculitis

Infections:

• secondary infection

Rare side effects (may affect up to 1 in 10,000 people)

Vascular disorders:

• telangiectasia (dilation of skin blood vessels or spider veins)

Side effects with unknown frequency (cannot be estimated from the available data)

Eye disorders:

• blurred vision

Other side effects in children

Children and adolescents may demonstrate a greater susceptibility than adult patients to suppression of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome induced by topical corticosteroid use, due to a greater surface-to-weight ratio. Chronic therapy with topical corticosteroids may interfere with growth and development in children.

Intracranial hypertension has been reported in children treated with topical corticosteroids. The manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) at www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Peitel

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month stated.

Store below 25°C.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Peitel:

• The active substance is prednicarbate.

Each gram of ointment contains 2.5 mg of prednicarbate

• The other ingredients (excipients) are: glycerol monooleate, octyldodecanol, edetic acid, petrolatum, benzyl alcohol, magnesium sulfate, and purified water.

Appearance of the product and pack contents

Peitel 2.5 mg/g ointment is a uniform, almost white ointment.

It is available in aluminum tubes containing 30 and 60 grams of ointment.

Other presentations:

Peitel 2.5 mg/g cream and Peitel 2.5 mg/g cutaneous solution.

Marketing authorization holder:

Galenicum Derma, S.L.U.

Ctra N-1, Km 36

28750 San Agustin del Guadalix (Madrid)

Spain

Manufacturer:

Ferrer Internacional, S.A.

Joan Buscallá, 1-9

08173 - Sant Cugat del Vallés (Barcelona)

Spain

Date of last revision of this leaflet: March 2021

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es/).